Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

著者: Cosette M. Wheeler, S. Rachel Skinner, Maria Rowena Del Rosario‐Raymundo, Suzanne M. Garland, Archana Chatterjee, Eduardo Lazcano‐Ponce, Jorge Salmerón, Shelly McNeil, Jack T. Stapleton, Céline Bouchard, Mark G. Martens, Deborah Money, Swee Chong Quek, Barbara Romanowski, Carlos Vallejos, Bram ter Harmsel, V N Prilepskaya, Kah Leng Fong, Henry C Kitchener, Galina Minkina, Yong Kuei Lim, Tanya Stoney, Nahida Chakhtoura, Margaret Cruickshank, Аlevtina M. Savicheva, Daniel Pereira Silva, Murdo Ferguson, Anco Molijn, Wim Quint, Karin Hardt, Dominique Descamps, P.V. Suryakiran, Naveen Karkada, Brecht Geeraerts, Gary Dubin, Frank Struyf - The Lancet 2016 被引用: 192